Spelling suggestions: "subject:"tetranuclear""
1 |
Role of mto2 in temporal and spatial regulation of cytoplasmic microtubule nucleation in Schizosaccharomyces pombeGroocock, Lynda M. January 2010 (has links)
The microtubule [MT] cytoskeleton of S. pombe is a highly dynamic network of filaments that facilitates intracellular transport, determines cell polarity and plays an essential role in chromosome separation during mitosis. In fission yeast, MTs are nucleated in a temporally and spatially regulated manner from sites called Microtubule Organising Centres [MTOCs], through the activity of both the g-tubulin complex [g-TuC] and the Mto1/2 complex. The Mto1/2 complex determines the localisation of the g-TuC at MTOCs, which change throughout the cell cycle. As cells enter mitosis the cytoplasmic array of MT bundles depolymerise. They are replaced by the intranuclear mitotic spindle and cytoplasmic spindle pole bodyderived astral MTs that in turn give way to the formation of the post-anaphase array. Although much is known about the properties of each type of MT array, the mechanism by which the timing of MT nucleation at different MTOCs is regulated over the cell cycle remains unclear. In the Mto1/2 complex, Mto1 is thought to provide the primary interaction with the g-TuC, and Mto2 functions by reinforcing this interaction. Due to the lack of structural information for the Mto1/2 complex, the molecular mechanism of Mto1/2- mediated assembly of the g-TuC at MTOCs is unknown. The aim of my study is to investigate the possibility that the Mto1/2 complex is able to promote g-TuC assembly by forming a direct template. In addition, I will attempt to determine the molecular role of Mto2 within the Mto1/2 complex and examine ways in which regulation of Mto2 may influence the function the Mto1/2 complex at specific MTOCs. As part of the investigation into the mechanism of Mto2 function, an in vitro analysis of recombinant protein demonstrated that in the absence of Mto1, purified Mto2 is able to self-interact as a tetramer. I have confirmed this interaction in vivo and have also shown that Mto2 forms a dimer as cells enter mitosis. However, in the context of an Mto1/2 complex the significance of the change in Mto2 oligomeric state remains unknown. Hydrodynamic analysis of a truncated form of the Mto1/2 complex suggests that it may form a heterotetramer, a hypothesis which is consistent with the equimolar levels of Mto2 and Mto1 protein within the cell. This information provides some structural insight as to how the Mto1/2 complex may interact with the g-TuC at MTOCs. Further analysis of the Mto1/2 complex revealed that in vivo, the Mto1-Mto2 interaction is disrupted during mitosis. This was found to correlate with the hyperphosphorylation of Mto2, which occurs as cells enter mitosis. Subsequently, an in vitro kinase assay demonstrated that phosphorylation of the Mto1/2 complex reduces the stability of the complex. Mass spectrometry techniques and sequence conservation were used to identify several phosphorylated residues within Mto2 and the ability of these mutants to bind to Mto1 was analysed in vivo and in vitro. In summary, in this study I have uncovered a mechanism which allows fission yeast cells to regulate the nucleation of cytoplasmic MT nucleation in a cell-cycle dependent manner, through a phosphorylation-dependent remodelling of the Mto1/2 complex.
|
2 |
Étude des réactions de spallation 136Xe + p et 136Xe + 12C à 1 GeV par nucléon auprès de l’accélérateur GSI (Darmstadt, Allemagne) / Study of the spallation reactions 136Xe + p and 136Xe + 12C at 1 GeV per nucleon at the GSI facility (Darmstadt, Germany)Gorbinet, Thomas 10 November 2011 (has links)
Les réactions 136Xe + p et 136Xe + 12C à 1 GeV par nucléon d’énergie cinétique du projectile dans le centre de masse ont été étudiées en cinématique inverse à l’aide du dispositif expérimental SPALADIN, installé auprès de l’accélérateur d’ions lourds de GSI. Ma thèse décrit l’analyse de ces collisions réalisées au printemps 2009. La détection en coïncidence des fragments de l’état final (résidu du projectile, neutrons et fragments légers chargés) avec une grande efficacité géométrique est obtenue par la combinaison de la cinématique inverse, d’un aimant dipolaire de grande ouverture physique et de l’utilisation de grands détecteurs. Ces coïncidences, mesurées événement par événement, nous ont permis de sélectionner, indépendamment du modèle de désexcitation, le pré-fragment, noyau excité issu de la cascade intranucléaire en fonction de son énergie d’excitation. Ainsi, nous avons pu étudier l’évolution du mécanisme de désexcitation (par exemple, l’évaporation de particules légères, la cassure binaire asymétrique ou la fragmentation multiple simultanée) en fonction de l’énergie d’excitation du pré-fragment. Les données de la réaction 136Xe + p sont comparées principalement à trois modèles de désexcitation (SMM, GEMINI++ et ABLA07) couplés au code de cascade intranucléaire INCL4. Si ces modèles semblent décrire globalement les observables de notre expérience, des désaccords significatifs sont apparus notamment en ce qui concerne la production des fragments de masse intermédiaire (IMF). La comparaison des données 136Xe + 12C avec celles de la réaction 136Xe + p fait apparaître une grande similitude dans la désexcitation des pré-fragments qui laisse entrevoir que la cascade intranucléaire mène, dans les deux cibles, aux mêmes types de pré-fragments sur la plage d’énergie d’excitation commune aux deux réactions (0 à 4 MeV par nucléon). Le régime d’excitation au-dessus de 4 MeV par nucléon, accessible uniquement pour la réaction 136Xe + 12C, montre une différence qualitative dans la désexcitation du pré-fragment, avec notamment une production beaucoup plus importante d’IMF, avec des multiplicités élevées par événement, qui croît avec l’énergie d’excitation. / The collision of 136Xe with the proton and with 12C at 1 GeV per nucleon of projectile kinetic energy in the centre of mass has been studied in inverse kinematics using the SPALADIN experimental setup at the GSI facility. This manuscript describes the analysis of these collisions realized in spring 2009. The detection in coincidence of the final state fragments (projectile residues, neutrons and light charged fragments) with a large geometrical efficiency is provided by the inverse kinematics combined with a large aperture dipole magnet and large detectors. Such a coincidence, measured on an event basis, allows selecting, in a model-independent way, the prefragment, the excited nuclear system formed after the intranuclear cascade as a function of its excitation energy. Hence, we were able to study the evolution of the prefragment deexcitation mechanism (evaporation of light particles, asymmetric binary decay, multiple fragmentation…) as a function of its excitation energy. The data of the 136Xe + p reaction have been compared mainly to three deexcitation models (SMM, GEMINI++ and ABLA07) coupled to the intranuclear cascade code INCL4. Despite the relatively good and global agreement between these models and our data, significant discrepancies appeared concerning in particular the production of intermediate mass fragments (IMF). Comparison between the 136Xe + 12C and the 136Xe + p data exhibits an important similarity in the deexcitation of the pre-fragments. This suggests that the nuclear cascade leads, for both targets, to similar prefragment types in the range of excitation energy (0 to 4 MeV per nucleon) common to both reactions. Higher excitation energies, reached only in the 136Xe + 12C reaction, show a qualitative difference in the deexcitation of the pre-fragment, with much higher multiplicities of IMF per event, increasing with the excitation energy.
|
3 |
Amélioration du modèle de cascade intranucléaire de Liège en vue de l'étude de cibles de spallation pour les systèmes hybridesAoust, Thierry 22 June 2007 (has links)
Lintérêt pour les réactions de spallation comme source intense de neutrons sest renouvelé ces dix dernières années avec les études de transmutation des actinides mineurs dans les systèmes hybrides (ADS).
Parmi les modèles de réaction de spallation, le modèle de cascade intranucléaire de Liège (INCL), couplé au modèle dévaporation ABLA, sest révélé être lun des plus prédictifs pour des nucléons incidents de 200 MeV à quelques GeV.
Cependant le modèle INCL présente encore quelques lacunes et fait donc encore lobjet de développements. Dans cette thèse nous avons tenté de remédier aux points suivants:
- évaluation du pic quasi-élastique en introduisant la dépendance en isospin et en énergie du champ nucléaire moyen des baryons,
- les voies faisant intervenir les pions en étendant les sections efficaces pion-nucléon de part et dautre de la résonnance D et en introduisant un potentiel moyen pour les pions déterminé par ajustement sur de nombreuses données expérimentales de production de pions et induites par des pions.
En vue de lextension du modèle INCL aux basses énergies nous avons également comparé ce modèle à des modèles de prééquilibre, en théorie mieux adaptés pour des énergies incidentes comprises entre 10 et 200 MeV.
Finalement nous avons étudié limpact de nos investigations pour létude de cibles de spallation épaisses et dADS.
Le résultat le plus important de nos recherches tant pour des cibles minces que pour la conception de cibles épaisses, est une nette amélioration (réduction) de lestimation des isotopes hautement radiotoxiques du Po à partir de cibles en Bi.
|
4 |
Intranuclear Rodlets: Dynamic Nuclear Bodies in Pancreatic Beta-Cells; and, A Novel Variant in Mouse CNS Neurons.Milman, Pavel 28 February 2013 (has links)
Intranuclear rodlets (INRs) are poorly understood intranuclear bodies originally identified within neuronal nuclei on the basis of their unique morphology. Their mechanism of formation, biochemical composition and physiological significance are largely unknown. To gain insight into the molecular regulators of INR formation, mice with a conditional adult β cell-specific knockout of the master regulator of β-cell metabolism, Lkb1 protein kinase (LABKO mice) were studied. The proportion of beta cells containing INRs was significantly reduced in LABKO mice. Further examination ruled out mTOR and Mark2 as downstream effectors of Lkb1 knockout INR phenotype. Instead it identified the mTOR pathway as an independent regulator of INR formation. To investigate INR changes in a pathophysiological context, β cell INRs were examined in two models of human metabolic syndrome: (1) mice maintained on a high-fat diet and (2) leptin-deficient ob/ob mice. Significant INR reduction was observed in both models. Taken together, our results support the view that INR formation in pancreatic β cells is a dynamic and regulated process. The substantial depletion of INRs in LABKO and obese diabetic mice suggests their relationship to β cell function and potential involvement in diabetes pathogenesis. The significance of these findings was further underscored by the demonstration of INRs in human endocrine pancreas, suggesting their potential relevance to the development of metabolic syndrome in humans.
The existence of biochemically distinct subtypes of INRs has been suggested by previous reports of differential immunological staining of INRs in neurochemically distinct neuronal populations. Here, a novel variant of INR has been identified that is immunoreactive for the 40kDa huntingtin associated protein and ubiquitin; and evidence was provided for the existence of additional INR subtypes sharing ubiquitin immunoreactivity as a common feature. Selective association of these INRs with melanin concentrating hormone and tyrosine hydroxylase immunoreactive neurons of the hypothalamus and the locus coeruleus was described. It was also demonstrated for the first time that biochemically distinct INR subtypes can co-exist within a single nucleus where they engage in non-random spatial interactions. These findings highlight the biochemical diversity and cell type specific expression of these enigmatic intranuclear structures. On the basis of these findings and previous literature a hypothesis is proposed as to the overall functional significance of INRs in the cell nucleus.
|
5 |
Intranuclear Rodlets: Dynamic Nuclear Bodies in Pancreatic Beta-Cells; and, A Novel Variant in Mouse CNS Neurons.Milman, Pavel 28 February 2013 (has links)
Intranuclear rodlets (INRs) are poorly understood intranuclear bodies originally identified within neuronal nuclei on the basis of their unique morphology. Their mechanism of formation, biochemical composition and physiological significance are largely unknown. To gain insight into the molecular regulators of INR formation, mice with a conditional adult β cell-specific knockout of the master regulator of β-cell metabolism, Lkb1 protein kinase (LABKO mice) were studied. The proportion of beta cells containing INRs was significantly reduced in LABKO mice. Further examination ruled out mTOR and Mark2 as downstream effectors of Lkb1 knockout INR phenotype. Instead it identified the mTOR pathway as an independent regulator of INR formation. To investigate INR changes in a pathophysiological context, β cell INRs were examined in two models of human metabolic syndrome: (1) mice maintained on a high-fat diet and (2) leptin-deficient ob/ob mice. Significant INR reduction was observed in both models. Taken together, our results support the view that INR formation in pancreatic β cells is a dynamic and regulated process. The substantial depletion of INRs in LABKO and obese diabetic mice suggests their relationship to β cell function and potential involvement in diabetes pathogenesis. The significance of these findings was further underscored by the demonstration of INRs in human endocrine pancreas, suggesting their potential relevance to the development of metabolic syndrome in humans.
The existence of biochemically distinct subtypes of INRs has been suggested by previous reports of differential immunological staining of INRs in neurochemically distinct neuronal populations. Here, a novel variant of INR has been identified that is immunoreactive for the 40kDa huntingtin associated protein and ubiquitin; and evidence was provided for the existence of additional INR subtypes sharing ubiquitin immunoreactivity as a common feature. Selective association of these INRs with melanin concentrating hormone and tyrosine hydroxylase immunoreactive neurons of the hypothalamus and the locus coeruleus was described. It was also demonstrated for the first time that biochemically distinct INR subtypes can co-exist within a single nucleus where they engage in non-random spatial interactions. These findings highlight the biochemical diversity and cell type specific expression of these enigmatic intranuclear structures. On the basis of these findings and previous literature a hypothesis is proposed as to the overall functional significance of INRs in the cell nucleus.
|
6 |
Misfolded superoxide dismutase-1 in sporadic and familial Amyotrophic Lateral Sclerosis / Felveckat superoxid dismutas-1 i sporadisk och familiär amyotrofisk lateralsklerosForsberg, Karin January 2011 (has links)
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative syndrome of unknown etiology that most commonly affects people in middle and high age. The hallmark of ALS is a progressive and simultaneous loss of upper and lower motor neurons in the central nervous system that leads to a progressive muscle atrophy, paralysis and death usually by respiratory failure. ALS is not a pure motor neuronal syndrome; it extends beyond the motor system and affects extramotor areas of the brain as well. The majority of the patients suffer from a sporadic ALS disease (SALS) while in at least ten percent the disease appears in a familial form (FALS). Mutations in the gene encoding the antioxidant enzyme superoxide dismutase-1 (SOD1) are the most common cause of FALS. More than 165 SOD1 mutations have been described, and these confer the enzyme a cytotoxic gain of function. Evidence suggests that the toxicity results from structural instability which makes the mutated enzyme prone to misfold and form aggregates in the spinal cord and brain motor neurons. Recent studies indicate that the wild-type human SOD1 protein (wt-hSOD1) has the propensity to develop neurotoxic features. The aim of the present study was to investigate if wt-hSOD1 is involved in the pathogenesis of SALS and FALS patients lacking SOD1 mutations and to evaluate the neurotoxic effect of misfolded wt-hSOD1 protein in vivo by generating a transgenic wt-hSOD1 mice model. We produced specific SOD1-peptide-generated antibodies that could discriminate between the misfolded and native form of the enzyme and optimized a staining protocol for detection of misfolded wt-hSOD1 by immunohistochemistry and confocal microscopy of brain and spinal cord tissue. We discovered that aggregates of misfolded wt-hSOD1 were constitutively present in the cytoplasm of motor neurons in all investigated SALS patients and in FALS patients lacking SOD1 gene mutations. Interestingly, the misfolded wt-hSOD1 aggregates were also found in some motor neuron nuclei and in the nuclei of the surrounding glial cells, mainly astrocytes but also microglia and oligodendrocytes, indicating that misfolded wt-hSOD1 protein aggregates may exert intranuclear toxicity. We compared our findings to FALS with SOD1 mutations by investigating brain and spinal cord tissue from patients homozygous for the D90A SOD1 mutation, a common SOD1 mutation that encodes a stable SOD1 protein with a wild-type-like enzyme activity. We observed a similar morphology with a profound loss of motor neurons and aggregates of misfolded SOD1 in the remaining motor neuron. Interestingly, we found gliosis and microvacuolar degeneration in the superficial lamina of the frontal and temporal lobe, indicating a possible frontotemporal lobar dementia in addition to the ALS disorder. Our morphological and biochemical findings were tested in vivo by generating homozygous transgenic mice that over expressed wt-hSOD1. These mice developed a fatal ALS-like disease, mimicking the one seen in mice expressing mutated hSOD1. The wt-hSOD1 mice showed a slower weight gain compared to non-transgenic mice and developed a progressive ALS-like hind-leg paresis. Aggregates of misfolded wt-hSOD1 were found in the brain and spinal cord neurons similar to those in humans accompanied by a loss of 41 % of motor neurons compared to non-transgenic litter mates. In conclusion, we found misfolded wt-hSOD1 aggregates in the cytoplasm and nuclei of motor neurons and glial cells in all patients suffering from ALS syndrome. Notable is the fact that misfolded wt-hSOD1 aggregates were also detected in FALS patients lacking SOD1 mutations indicating a role for SOD1 even when other genetic mutations are present. The neurotoxicity of misfolded wt-hSOD1 protein was confirmed in vivo by wt-hSOD1 transgenic mice that developed a fatal ALS-like disease. Taken together, our results support the notion that misfolded wt-hSOD1 could be generally involved and play a decisive role in the pathogenesis of all forms of ALS.
|
7 |
Intranuclear Rodlets: Dynamic Nuclear Bodies in Pancreatic Beta-Cells; and, A Novel Variant in Mouse CNS Neurons.Milman, Pavel January 2013 (has links)
Intranuclear rodlets (INRs) are poorly understood intranuclear bodies originally identified within neuronal nuclei on the basis of their unique morphology. Their mechanism of formation, biochemical composition and physiological significance are largely unknown. To gain insight into the molecular regulators of INR formation, mice with a conditional adult β cell-specific knockout of the master regulator of β-cell metabolism, Lkb1 protein kinase (LABKO mice) were studied. The proportion of beta cells containing INRs was significantly reduced in LABKO mice. Further examination ruled out mTOR and Mark2 as downstream effectors of Lkb1 knockout INR phenotype. Instead it identified the mTOR pathway as an independent regulator of INR formation. To investigate INR changes in a pathophysiological context, β cell INRs were examined in two models of human metabolic syndrome: (1) mice maintained on a high-fat diet and (2) leptin-deficient ob/ob mice. Significant INR reduction was observed in both models. Taken together, our results support the view that INR formation in pancreatic β cells is a dynamic and regulated process. The substantial depletion of INRs in LABKO and obese diabetic mice suggests their relationship to β cell function and potential involvement in diabetes pathogenesis. The significance of these findings was further underscored by the demonstration of INRs in human endocrine pancreas, suggesting their potential relevance to the development of metabolic syndrome in humans.
The existence of biochemically distinct subtypes of INRs has been suggested by previous reports of differential immunological staining of INRs in neurochemically distinct neuronal populations. Here, a novel variant of INR has been identified that is immunoreactive for the 40kDa huntingtin associated protein and ubiquitin; and evidence was provided for the existence of additional INR subtypes sharing ubiquitin immunoreactivity as a common feature. Selective association of these INRs with melanin concentrating hormone and tyrosine hydroxylase immunoreactive neurons of the hypothalamus and the locus coeruleus was described. It was also demonstrated for the first time that biochemically distinct INR subtypes can co-exist within a single nucleus where they engage in non-random spatial interactions. These findings highlight the biochemical diversity and cell type specific expression of these enigmatic intranuclear structures. On the basis of these findings and previous literature a hypothesis is proposed as to the overall functional significance of INRs in the cell nucleus.
|
8 |
Proteomic analysis of polyglutamine disease in drosophila.January 2005 (has links)
Lam Wun. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2005. / Includes bibliographical references (leaves 140-153). / Abstracts in English and Chinese. / ABSTRACT --- p.i / ACKNOWLDGEMENT --- p.iii / TABLE OF CONTENT --- p.iv / ABBREVIATIONS --- p.x / LISTS OF TABLES --- p.xi / LISTS OF FIGURES --- p.xii / Chapter 1. --- INTRODUCTION / Chapter 1.1 --- Neurodegeneration and triplet repeat diseases --- p.1 / Chapter 1.2 --- Polyglutamine diseases --- p.2 / Chapter 1.3 --- Polyglutamine nuclear inclusions --- p.4 / Chapter 1.3.1 --- Kinetics of polyglutamine nuclear inclusion formation --- p.4 / Chapter 1.3.2 --- Roles of protein inclusions in neurodegeneration --- p.7 / Chapter 1.4 --- Polyglutamine pathogenic pathways --- p.8 / Chapter 1.4.1 --- Protein depletion theory --- p.9 / Chapter 1.4.2 --- Induction of apoptotic pathways --- p.13 / Chapter 1.5 --- Previous study on NI proteins --- p.14 / Chapter 1.6 --- Drosophila model for studying polyglutamine diseases --- p.15 / Chapter 1.6.1 --- Drosophila model for studying human diseases --- p.15 / Chapter 1.6.2 --- GAL4/UAS gene expression system --- p.15 / Chapter 1.6.3 --- Drosophila polyglutamine models --- p.17 / Chapter 1.7 --- Objectives of the study --- p.21 / Chapter 2. --- MATERIALS AND METHODS / Chapter 2.1 --- Drosophila genetics --- p.22 / Chapter 2.1.1 --- Drosophila culture --- p.22 / Chapter 2.1.2 --- GAL4/UAS gene expression system --- p.22 / Chapter 2.1.3 --- Eye phenotypic analysis --- p.25 / Chapter 2.1.4 --- Polyglutamine fly models --- p.25 / Chapter 2.1.5 --- Generation and characterization of GFP-polyglutamine transgenic fly models --- p.25 / Chapter 2.2 --- Proteomic identification of nuclear inclusion proteins --- p.26 / Chapter 2.2.1 --- Proteomic identification of NI proteins by SDS-insolubility of NIs --- p.26 / Chapter 2.2.2 --- Proteomic identification of NI proteins by FA-solubility of NIs --- p.27 / Chapter 2.2.2.1 --- Approach overview --- p.27 / Chapter 2.2.2.2 --- Sample preparation for two-dimensional gel electrophoresis --- p.27 / Chapter 2.2.2.3 --- Two-dimensional gel electrophoresis --- p.29 / Chapter 2.2.2.4 --- Polyacrylamide gel staining --- p.31 / Chapter 2.2.2.5 --- Computer analysis of 2D patterns --- p.31 / Chapter 2.2.2.6 --- In-gel trypsin digestion --- p.32 / Chapter 2.2.2.7 --- Mass spectrometric analysis --- p.33 / Chapter 2.2.3 --- Detection of NIs by flow cytometry --- p.34 / Chapter 2.3 --- SDS-polyacrylamide gel electrophoresis (SDS-PAGE) --- p.34 / Chapter 2.3.1 --- Sample preparation for SDS-PAGE --- p.34 / Chapter 2.3.2 --- SDS-PAGE --- p.35 / Chapter 2.4 --- Immunodetection --- p.36 / Chapter 2.4.1 --- Electroblotting --- p.36 / Chapter 2.4.2 --- Western blotting --- p.36 / Chapter 2.4.3 --- Filter trap assay --- p.37 / Chapter 2.5 --- Sav antibody production --- p.38 / Chapter 2.5.1 --- Sav peptide synthesis --- p.38 / Chapter 2.5.2 --- Rabbit immunization --- p.38 / Chapter 2.6 --- Cryosectioning and immunostaining of adult fly heads --- p.39 / Chapter 2.7 --- Alcohol dehydrogenase assay --- p.40 / Chapter 2.8 --- Semi-quantitative reverse transcription- Polymerase Chain Reaction --- p.41 / Chapter 2.8.1 --- Total RNA preparation from fly heads --- p.41 / Chapter 2.8.2 --- Reverse transcription- Polymerase Chain Reaction (RT-PCR) --- p.41 / Chapter 2.9 --- Reagents and buffers --- p.42 / Chapter 3. --- RESULTS / Chapter 3.1 --- Transgenic polyglutamine fly models --- p.48 / Chapter 3.1.1 --- Characteristics of MJD polyglutamine fly model --- p.48 / Chapter 3.1.1.1 --- Overexpression of expanded truncated human MJD proteins in Drosophila causes eye degeneration --- p.49 / Chapter 3.1.1.2 --- Overexpression of expanded truncated human MJD proteins in Drosophila results in nuclear inclusion formation --- p.49 / Chapter 3.1.1.3 --- Formic acid dissolves fly polyglutamine nuclear inclusions --- p.51 / Chapter 3.1.1.3.1 --- Formic acid dissolves fly polyglutamine NIs as shown by Western blot analysis --- p.51 / Chapter 3.1.1.3.2 --- Formic acid dissolves fly polyglutamine NIs as shown by filter trap assay --- p.53 / Chapter 3.1.2 --- Summary --- p.55 / Chapter 3.2 --- Proteomic identification of nuclear inclusion (NI) proteins --- p.56 / Chapter 3.2.1 --- Proteomic identification of NI proteins by SDS-insolubility of NIs --- p.56 / Chapter 3.2.2 --- Proteomic identification of NI proteins by FA-solubility of NIs --- p.63 / Chapter 3.2.2.1 --- Two-dimensional gels showing differential protein spots as potential NI proteins --- p.63 / Chapter 3.2.2.2 --- NI protein candidates identified by the 2D approach --- p.75 / Chapter 3.2.3 --- Study of polyglutamine NI proteins by flow cytometry analysis --- p.90 / Chapter 3.2.3.1 --- Detection of fly polyglutamine NIs by flow cytometry --- p.90 / Chapter 3.2.3.2 --- Characterization of a new GFP-polyglutamine fly model --- p.92 / Chapter 3.3 --- Characterization of the nuclear inclusion protein candidates --- p.96 / Chapter 3.3.1 --- Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) --- p.96 / Chapter 3.3.1.1 --- Confirmation of GAPDH as a NI protein --- p.97 / Chapter 3.3.1.2 --- Discussion --- p.97 / Chapter 3.3.2 --- Receptor of activated protein kinase C (RACK1) --- p.99 / Chapter 3.3.2.1 --- Confirmation of RACK1 as a NI protein --- p.99 / Chapter 3.3.2.1.1 --- Colocalization of RACK1 with NIs --- p.99 / Chapter 3.3.2.1.2 --- Formic Acid extracts RACK1 from NIs --- p.101 / Chapter 3.3.2.2 --- Reduction of soluble RACK1 protein level in polyglutamine fly --- p.101 / Chapter 3.3.2.2.1 --- Soluble RACK1 protein level reduced in polyglutamine fly --- p.101 / Chapter 3.3.2.2.2 --- RACK1 transcript level remains unchanged in polyglutamine fly --- p.103 / Chapter 3.3.2.3 --- Overexpression of RACK 1 partially suppresses polyglutamine degeneration --- p.105 / Chapter 3.3.2.4 --- Discussion --- p.107 / Chapter 3.3.3 --- Warts (Wts) --- p.111 / Chapter 3.3.3.1 --- Overexpression of Wts partially suppresses polyglutamine degeneration --- p.111 / Chapter 3.3.3.2 --- Wts mutant slightly enhances polyglutamine degeneration --- p.113 / Chapter 3.3.3.3 --- Genetic analysis of Warts pathway in polyglutamine pathogenesis --- p.113 / Chapter 3.3.3.3.1 --- Overexpression of Salvador partially suppresses polyglutamine degeneration --- p.116 / Chapter 3.3.3.3.2 --- Hpo mutant slightly enhances polyglutamine degeneration --- p.119 / Chapter 3.3.3.3.3 --- Overexpression of DIAP1 partially suppresses polyglutamine degeneration --- p.119 / Chapter 3.3.3.4 --- Discussion --- p.121 / Chapter 3.3.4 --- Alcohol dehydrogenase (Adh) --- p.122 / Chapter 3.3.4.1 --- Adh activity is reduced in polyglutamine flies --- p.122 / Chapter 3.3.4.2 --- Overexpression of Hsp70 partially restores the reduced Adh activity in polyglutamine flies --- p.122 / Chapter 3.3.4.3 --- Discussion --- p.125 / Chapter 3.3.5 --- Genetic analysis of other NI protein candidates --- p.127 / Chapter 3.3.5.1 --- Overexpression of CG7920 protein partially suppresses polyglutamine degeneration --- p.127 / Chapter 3.3.5.2 --- Pten dsRNA slightly enhances polyglutamine degeneration --- p.129 / Chapter 3.3.6 --- Summary --- p.131 / Chapter 4. --- DISSCUSSION / Chapter 4.1 --- Protein depletion theory --- p.133 / Chapter 4.2 --- Comparison of different approaches for identification of NI proteins --- p.134 / Chapter 4.3 --- Long-term significance --- p.136 / Chapter 4.4 --- Future studies --- p.137 / Chapter 4.4.1 --- Characterization of other NI protein candidates --- p.137 / Chapter 4.4.2 --- Study of NI proteins by an alternative approach --- p.137 / Chapter 4.4.3 --- Study of NI proteins using other polyglutamine fly models --- p.137 / Chapter 5. --- CONCLUSION --- p.139 / Chapter 6. --- REFERENCES --- p.140
|
9 |
Trafic intranucléaire de l’ARN de la télomérase et la réponse aux dommages à l’ADN chez la levure Saccharomyces cerevisiaeOuenzar, Faissal 08 1900 (has links)
Les cassures double-brins d’ADN (CDBs) constituent une menace pour la viabilité cellulaire et l’intégrité du génome puisque l’absence de la réparation d’une CDB pourrait conduire à la mort cellulaire. En plus de la réparation par jonction d’extrémités nonhomologues (NHEJ) en phase G1 et de la recombinaison homologue (RH) en phase S et G2, les CDBs peuvent être réparées par l’ajout de télomères par l’action de la télomérase; un phénomène qui s’appelle l’ajout de télomères de novo. Ce phénomène pourrait mettre en danger la stabilité génomique parce qu’il engendre, dans la plupart des cas, une perte du bras chromosomique du fragment non-centromérique. En conséquence, ceci engendre soit une perte de l’hétérozygotie (LOH) dans les cellules diploïdes ou la mort cellulaire dans les cellules haploïdes. Dans le but d’empêcher la formation de télomères de novo, la cellule possède des mécanismes et des voies qui préviennent l’action inappropriée de la télomérase à des CDBs. Une des principales questions dans le domaine est de comprendre comment la cellule inhibe l’ajout de télomères de novo par la télomérase en favorisant la réparation des CDBs par les autres voies (NHEJ et la RH).Dans ce projet, nous utilisons la technique d’hybridation in situ en fluorescence (FISH) sur le facteur limitant de la télomérase, l’ARN TLC1 de la levure S. cerevisiae. Nous avons pu montrer que l’ARN TLC1 fait un trafic intranucléaire durant le cycle cellulaire des cellules sauvages. En phase G1/S, l’ARN TLC1 adopte une localisation nucléoplasmique avec les télomères, alors qu’il s’accumule au nucléole en phase G2/M. Nous avons fait l’hypothèse que l’accumulation de l’ARN TLC1 au nucléole en G2/M pourrait réduire la compétition entre la RH, qui est exclusivement nucléoplasmique, et la télomérase pour la réparation des CDBs. Pour tester cette hypothèse, nous avons employé la bléomycine (blm), un composé chimique générant des CDBs, pour traiter des cellules sauvages ou déficientes de la RH par la délétion du gène RAD52. Nous avons observé que l’ARN TLC1 conserve une localisation nucléolaire dans les cellules sauvages traitées par la blm en phase G2/M, alors que dans lescellules délétées de RAD52 exposées à la blm, l’ARN TLC1 se localise maintenant au nucléoplasme et s’associe partiellement aux sites de cassures. De plus, nous avons trouvé que l’accumulation nucléoplasmique de l’ARN TLC1 dans les cellules délétéées de RAD52 traitées à la blm, dépend de la voie de dommage à l’ADN (MRX, ATM/Tel1 et ATR/Mec1) et de la sumoylation par la SUMO E3ligase, Siz1. Plus particulièrement, l’association de la télomérase à des CDBs dépend de son interaction avec Cdc13, une protéine qui recrute la télomérase aux télomères. D’une manière surprenante, nous avons observé une accumulation rapide de Cdc13 à des CDBs en absence de Rad52, bien que nos résultats suggèrent que Rad52 empêche l’accumulation de l’ARN TLC1 au nucléoplasme par l’inhibition de l’accumulation de Cdc13 aux sites de cassures. L’ensemble de nos résultats ont mis en évidence que la télomérase est normalement exclue des sites de la réparation d’ADN. Cependant, en absence d’une voie fonctionnelle de la RH, la télomérase se localise du nucléole au nucléoplasme et s’accumule partiellement à des CDBs
d’une manière dépendante de Cdc13 et Siz1. / DNA double-strand breaks (DSB) constitute a threat to genome integrity and cell survival if they are not repaired. In addition to canonical DNA repair systems such as nonhomologous end joining (NHEJ) in G1 and homologous recombination (HR) in S and G2 phases, DSBs can also be repaired by addition of new telomeres by telomerase. This phenomenon is referred to as telomere healing or de novo telomere addition. This process threatens genome stability since it results in chromosome arm loss, which could be lethal in haploid cells and lead to loss of heterozygosity (LOH) in diploid cells. Therefore, cells possess mechanisms that prevent the untimely action of telomerase on DSBs. One of the questions driving this field is to understand how telomere addition by telomerase is inhibited and DSBs repair can be efficiently performed by canonical DSB repair (NHEJ and HR). In this project, we used fluorescent in situ hybridization (FISH) to detect the endogenous TLC1 RNA, which is the limiting component of telomerase of the budding yeast. Using this technique, we found that TLC1 RNA traffics inside the nucleus during the cell cycle of wild-type cells. In G1 and S phases, TLC1 RNA adopts a nucleoplasmic localization, which is related to its function in telomere elongation, while it accumulates in the nucleolus in G2/M. We hypothesize that the nucleolar accumulation of TLC1 RNA in G2/M may reduce the possibility that telomerase interferes with HR to repair DNA DSB, since HR is excluded from the nucleolus and occurs only in the nucleoplasm. To test this hypothesis, we treated wild-type and rad52 (HR deficient cells) with bleomycin, a radiomimetic agent that generates preferentially DSBs. Our results show that after induction of DSB with bleomycin, TLC1 RNA remains nucleolar in wild-type cells in G2/M, but accumulates in the nucleoplasm and colocalizes partially with DSBs sites in rad52 cells, suggesting that RAD52 inhibits the nucleoplasmic accumulation of TLC1 RNA in the presence of DSBs. Nucleoplasmic accumulation of TLC1 RNA after DSB induction requires the DNA damage pathway (MRX, ATM/Tel1 and ATR/Mec1), and the SUMO ligase E3 Siz1. Interestingly, association of TLC1 RNA with DSBs depends on the single-strand telomeric binding protein Cdc13, which rapidly accumulates at sites of DNA damage, while Rad52 suppresses this process by inhibiting Cdc13 accumulation at DSBs. These results suggest that telomerase is normally excluded from sites of DNA repair. In the absence of functional homologous recombination, telomerase leaves the nucleolus and accumulates partially at DSB in the nucleoplasm in a Cdc13- and Siz1-dependent manner.
|
10 |
Polyhistidine repeats and Dyrk 1a: from the localization on the functionSalichs Fradera, Eulàlia 15 December 2008 (has links)
PolyHistidine repeats and DYRK1A: from the localization to the functionEl principal objectiu d'aquesta tesi ha estat el d'esbrinar noves funcions de la proteína quinasa DYRK1A en el nucli cel.lular. Donat que el domini de repetició d'histidines de DYRK1A dirigeix la proteína al compartiment d'speckles nuclears, aquesta propietat ha estat utilitzada per adreçar aquesta pregunta. Els resultats obtinguts en aquesta tesi han permès proposar els homopolímers d'histidina com una nova i general senyal de localització a speckles nuclears. Proteïnes amb segments de polihistidines, la majoria d'elles factors de transcripció, mostren un comportament intranuclear dinàmic, compatible amb un model en el quèl diferents dominis d'interacció competeixen entre ells pel reclutament de la proteína a diferents subcompartiments nuclears. El mecanisme molecular que media l'acumulació a speckles de les proteïnes amb polihistines s'ha estudiat utilitzant DYRK1A com a model. Els resultats obtinguts exclouen la unió a l'RNA com a mecanisme de reclutament i concloure que, aquest, ocorre mitjançant la interacció amb proteïnes residents. S'han identificat dues noves proteïnes interactores per a DYRK1A, l'RNA polimerasa II i el factor de transcripció Brn-3b. La fosforilació de DYRK1A sobre el domini C-terminal o CTD de l'RNA polimerasa II suggereix una funció directa de la quinasa en el procés de transcripció o del seu acoblament al processament d'RNAs missatgers. La fosforilació de DYRK1A sobre el domini d'activació de Brn-3b sembla regular positivament l'activitat transcripcional d'aquest factor. Aquests resultats indiquen una funció activa de DYRK1A en la regulació de la transcripció gènica, tant directament sobre la maquinària transcripcional com indirectament, modulant l'activitat de factors de transcripció. PolyHistidine repeats and DYRK1A: from the localization to the functionThe main objective of this thesis work has been to identify new roles for the protein kinase DYRK1A in the cell nucleus. Given that a histidine repeat in DYRK1A targets the protein to the nuclear speckle compartment, this property has been used as a tool to approach the question. The results obtained in this thesis work have allowed proposing homopolymeric histidine runs as a novel and general nuclear speckle-directing signal. Proteins with polyHistidine segments, mostly transcription factors, present a dynamic intranuclear behaviour compatible with a model in which distinct interacting domains compete for recruiting elements within the nucleus. The molecular mechanisms that mediate speckle accumulation have been studied in DYRK1A as a model system. The results allow excluding RNA binding as the recruiting mechanism and concluding that targeting is mediated by interaction with speckle-resident proteins. Two novel DYRK1A interactors have been identified during the study, the RNA polymerase II and the transcription factor Brn-3b. DYRK1A phosphorylation of the C-terminal domain or CTD of the RNA polymerase II suggests a direct role of DYRK1A on transcription or coupling of transcription with RNA processing. DYRK1A phosphorylation of Brn-3b within its activation domain seems to positively regulate Brn-3b transcriptional activity. These results confirm an active role for DYRK1A in gene transcription regulation both direct on the transcriptional machinery and indirect by modulating the activity of transcription factors.
|
Page generated in 0.0631 seconds